Patents by Inventor Michael A. Lyons
Michael A. Lyons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20100071929Abstract: A geometrically-structured coaxial cable may prevent infiltration of water vapor and other contaminants by using a closed cell structure. The cable may be fabricated by wrapping bubble tape around its central conductor. Alternatively, plastic may be extruded through channels to create a plurality of layers. In either case, these layers are staggered in a zig-zag pattern to ensure that no radial spokes connect the inner and outer conductors of the coaxial cable without passing through a plurality of dielectric layers.Type: ApplicationFiled: September 25, 2008Publication date: March 25, 2010Applicants: Lucent Technologies Inc., Alcatel-LucentInventors: Jan Hesselbarth, Erhard Mahlandt, Alan Michael Lyons
-
Patent number: 7678495Abstract: A method and apparatus are disclosed wherein a battery comprises at least one electrode formed from a graphitic carbon nanostructured surface wherein the nanostructured surface consists of a plurality of nanoposts formed from graphitic carbon such that the graphitic nanoposts serve both as an operational feature (i.e., dielectric/electrode) and control feature of the battery itself. In one embodiment, the nanostructured surface consists of a plurality of nanoposts wherein a select portion of each nanopost is formed to serve as the dielectric of the nanostructured battery, and the balance of each nanopost is utilized to impart the control features to the nanostructured battery.Type: GrantFiled: January 31, 2005Date of Patent: March 16, 2010Assignee: Alcatel-Lucent USA Inc.Inventors: Paul Robert Kolodner, Thomas Nikita Krupenkine, Alan Michael Lyons, Stanley Pau, Joseph Ashley Taylor, Brijesh Vyas
-
Patent number: 7674981Abstract: A geometrically-structured coaxial cable may prevent infiltration of water vapor and other contaminants by using a closed cell structure. The cable may be fabricated by wrapping bubble tape around its central conductor. Alternatively, plastic may be extruded through channels to create a plurality of layers. In either case, these layers are staggered in a zig-zag pattern to ensure that no radial spokes connect the inner and outer conductors of the coaxial cable without passing through a plurality of dielectric layers.Type: GrantFiled: September 25, 2008Date of Patent: March 9, 2010Assignee: Alcatel-Lucent USA Inc.Inventors: Jan Hesselbarth, Erhard Mahlandt, Alan Michael Lyons
-
Publication number: 20090315173Abstract: An apparatus 100 comprising a first substrate 130 having a first surface 125, a second substrate 132 having a second surface 127 facing the first surface and an array 170 of metallic raised features 170 being located on the first surface, each raised feature being in contact with the first surface to the second surface, a portion of the raised features being deformed via a compressive force 305.Type: ApplicationFiled: June 20, 2008Publication date: December 24, 2009Applicant: Lucent Technologies Inc.Inventors: Roger Scott Kempers, Shankar Krishnan, Alan Michael Lyons, Todd Richard Salamon
-
Publication number: 20090302974Abstract: An apparatus 100 comprising a radiofrequency filter body housing 102. The radiofrequency filter body housing includes a polymeric composition 110 that includes at least one polymer foam 115 and filler material 120. The filler material is uniformly distributed and randomly oriented throughout the polymeric composition. The radiofrequency filter body housing also includes an electrically conductive material 125 coating the polymeric composition.Type: ApplicationFiled: June 4, 2008Publication date: December 10, 2009Applicant: Lucent Technologies Inc.Inventors: Alan Michael Lyons, Todd Richard Salamon
-
Publication number: 20090297476Abstract: The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments provide compounds of the general Formula II, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.Type: ApplicationFiled: May 9, 2008Publication date: December 3, 2009Applicants: InterMune, Inc., Array Biopharma Inc.Inventors: SCOTT SEIWERT, STEVEN W. ANDREWS, LEONID BEIGELMAN, LAWRENCE M. BLATT, BRAD BUCKMAN, Kevin R. Condroski, Yutong Jiang, Robert J. Kaus, April L. Kennedy, Timonthy S. Kercher, Michael A. Lyon, Bin Wang
-
Publication number: 20090295487Abstract: A multistage amplifier and design method are disclosed. The multistage amplifier has a plurality of amplifier stages, each stage having an amplifier designed and biased to operate at or near the amplifier's power added efficiency (PAE) peak. The PAE peak of each of the amplifier is at or near the amplifiers linear-compression transition region, providing a multistage power amplifier that is power efficient and has desirable amplitude to amplitude and amplitude to phase power transfer characteristics. The amplifier is designed by matching the output impedance of a final stage with a load. Amplifier stages are iteratively designed from the last stage to the first. At each stage, an amplifier and drive circuit are designed. The drive circuit and amplifier are designed to provide each stage with output impedance matched to the input impedance of the following stage and to operate at or near the PAE peak of the amplifier.Type: ApplicationFiled: August 10, 2009Publication date: December 3, 2009Applicant: VIASAT, INC.Inventors: Kenneth V. Buer, Michael Lyons, Scarlet Daoud
-
Patent number: 7618746Abstract: A cell-array battery is disclosed having end-of-life cells that can be activated at the end of a battery's life to, illustratively, neutralize the toxic chemicals inside the battery. In one embodiment, neutralization of the electrolyte in the battery is achieved through immobilization of the electrolyte at the end of the life of the battery by, for example, a vitrification process. Using electrowetting techniques, the electrolyte is made to contact a neutralizing substance between the nanostructures in one or more end-of-life cells, thus causing a reaction that results in the electrolyte becoming immobilized by, for example, a polymer substance. In a second illustrative embodiment, when the electrolyte contacts the substance between the nanostructures in one or more end-of-life cells, the chemical composition of the electrolyte is changed into a less toxic chemical compound, thus neutralizing the electrolyte.Type: GrantFiled: March 18, 2004Date of Patent: November 17, 2009Assignees: Alcatel-Lucent USA Inc., mPhase Technologies, Inc.Inventors: Timofei Nikita Kroupenkine, Alan Michael Lyons, Steven David Simon, Joseph Ashley Taylor, Brijesh Vyas
-
Publication number: 20090242036Abstract: Device including channel having channel input and output. Channel has interior channel surface extending along channel path from channel input to output. In one implementation, channel includes plurality of channel sections in serial communication along channel path. Each of channel sections includes first internal circumference spaced apart along channel path from second internal circumference, in each of channel sections the first and second internal circumferences being substantially different. Each of channel sections includes sub-surface of interior channel surface. At least region of sub-surface of each channel section includes distribution of raised micro-scale features. As another implementation, at least first region of interior channel surface includes distribution of raised micro-scale features interrupted by plurality of raised barriers spaced apart along channel path on interior channel surface.Type: ApplicationFiled: March 31, 2008Publication date: October 1, 2009Applicant: Lucent Technologies, Inc.Inventors: Paul Robert Kolodner, Avinoam Kornblit, Thomas Nikita Krupenkin, Alan Michael Lyons, Todd Richard Salamon
-
Publication number: 20090242175Abstract: Device having first wick evaporator including first membrane and plurality of first thermally-conductive supports. First membrane has upper and lower surfaces. First membrane also has plurality of pores with upper pore ends at upper surface of first membrane and with lower pore ends at lower surface of first membrane. Each of first thermally-conductive supports has upper and lower support ends. Upper support ends of first thermally-conductive supports are in contact with first membrane. Each of first thermally-conductive supports has longitudinal axis extending between the upper and lower support ends, average cross-sectional area along axis, and membrane support cross-sectional area at upper support end, the membrane support cross-sectional area effectively being smaller than average cross-sectional area. First thermally-conductive supports are configured to conduct thermal energy from lower support ends of first thermally-conductive supports to first membrane.Type: ApplicationFiled: March 31, 2008Publication date: October 1, 2009Applicant: Lucent Technologies, Inc.Inventors: Nagesh R. Basavanhally, Marc Scott Hodes, Paul Robert Kolodner, Avinoam Kornblit, Thomas Nikita Krupenkin, Lee Wonsuck, Alan Michael Lyons, Todd Richard Salamon, Brijesh Vyas
-
Publication number: 20090248141Abstract: Medical devices for in vivo medical applications are disclosed. The medical devices are constructed of shape memory polymer (SMP) materials capable of assuming a memory shape at physiological temperatures. These medical devices may be used in surgical procedures and in both vascular and non-vascular applications. These SMP medical devices have a post-implantation memory shape that is substantially identical to or slightly larger than the insertion site to adapt to vessel growth or size changes. SMP medical devices may be formed as stents or occlusion devices (i.e., plugs) having a number of different structural features. The SMP medical devices may be formed from a first monomer and a second cross-linking monomer, wherein the weight percentages of the first and second monomers are selected by performing an iterative function to reach a predetermined glass transition temperature (Tg) and a predetermined rubbery modulus to optimize post-implantation memory shape properties of the devices.Type: ApplicationFiled: March 30, 2007Publication date: October 1, 2009Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADOInventors: Robin Shandas, Christopher M. Yakacki, Kenneth Gall, Alex E. Eckstein, Michael Lyons, Devatha P. Nair
-
Publication number: 20090233156Abstract: A cell-array battery is disclosed having end-of-life cells that can be activated at the end of a battery's life to, illustratively, neutralize the toxic chemicals inside the battery. In one embodiment, neutralization of the electrolyte in the battery is achieved through immobilization of the electrolyte at the end of the life of the battery by, for example, a vitrification process. Using electrowetting techniques, the electrolyte is made to contact a neutralizing substance between the nanostructures in one or more end-of-life cells, thus causing a reaction that results in the electrolyte becoming immobilized by, for example, a polymer substance. In a second illustrative embodiment, when the electrolyte contacts the substance between the nanostructures in one or more end-of-life cells, the chemical composition of the electrolyte is changed into a less toxic chemical compound, thus neutralizing the electrolyte.Type: ApplicationFiled: March 18, 2004Publication date: September 17, 2009Inventors: Timofei Nikita Kroupenkine, Alan Michael Lyons, Steven David Simon, Joseph Ashley Taylor, Brijesh Vyas
-
Publication number: 20090233119Abstract: An improved electrical connector for use with a glazing is disclosed. The glazing preferably comprises a ply of glazing material having a first electrically conductive component mounted thereon, and a second electrically conductive component, joined to the first by a lead-free solder. The second component has a thickness t and comprises first and second connector feet linked by a bridge portion, the bridge portion being at a height h above each of the connector feet. T and/or h are chosen to minimise the occurrence of stress faults in the glass in the region of the solder. Preferably, the glazing is an automotive glazing.Type: ApplicationFiled: March 23, 2007Publication date: September 17, 2009Applicant: Pikington Group LimitedInventor: Michael Lyon
-
Patent number: 7583150Abstract: A multistage amplifier and design method are disclosed. The multistage amplifier has a plurality of amplifier stages, each stage having an amplifier designed and biased to operate at or near the amplifier's power added efficiency (PAE) peak. The PAE peak of each of the amplifier is at or near the amplifiers linear-compression transition region, providing a multistage power amplifier that is power efficient and has desirable amplitude to amplitude and amplitude to phase power transfer characteristics. The amplifier is designed by matching the output impedance of a final stage with a load. Amplifier stages are iteratively designed from the last stage to the first. At each stage, an amplifier and drive circuit are designed. The drive circuit and amplifier are designed to provide each stage with output impedance matched to the input impedance of the following stage and to operate at or near the PAE peak of the amplifier.Type: GrantFiled: March 20, 2007Date of Patent: September 1, 2009Assignee: ViaSat, Inc.Inventors: Kenneth V Buer, Michael Lyons, Scarlet Daoud
-
Publication number: 20090209673Abstract: A laser can be used to modify a glazing 100, 300 so as to improve its suitability for use with a signal-receiving device 350 or a signal-transmitting device 350. This is done by using the laser to provide a region of reduced opacity 110, 202, 340 to the signal within the glazing. Preferably, the laser is be used to reduce the opacity of a selected region 340 of a tinted interlayer in situ. The glazing may be for a vehicle, especially an automotive vehicle.Type: ApplicationFiled: January 6, 2006Publication date: August 20, 2009Applicant: PILKINGTON GROUP LIMITEDInventors: Michael Lyon, Michael Robert Greenall
-
Publication number: 20090188264Abstract: An apparatus, method and system are provided for a modular in-frame pumped refrigerant distribution system. Specifically, a micro-channel heat exchanger is positioned in an equipment cabinet close to equipment that generates heat. More specifically, the micro-channel heat exchanger may be positioned on a) a shelf above the equipment, b) the back side of the equipment, or c) a shelf below the equipment. The micro-channel heat exchanger is operable to receive a refrigerant supplied by an external heat exchanger along a primary flow path, transfer heat from air above and/or near the equipment to a coil of the micro-channel heat exchanger, circulate the refrigerant to extract the heat, and return the refrigerant with an extracted portion of generated heat to the external heat exchanger along a secondary flow path. The external heat exchanger may remove extracted heat from a building via a building chilled water system or an outdoor condenser unit.Type: ApplicationFiled: January 25, 2008Publication date: July 30, 2009Inventors: Philip Chappelle Fair, Marc Scott Hodes, Wei Ling, Alan Michael Lyons, Salvatore Joseph Messana, Paul Mark Rominski, Majid Safavi, William Harold Scofield
-
Publication number: 20090169510Abstract: The embodiments provide compounds of the general Formulae I through general Formula VIII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.Type: ApplicationFiled: April 18, 2008Publication date: July 2, 2009Applicants: InterMune, Inc., Array BioPharma, Inc.Inventors: Lawrence M Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher, Bradley Barnett, C. Todd Eary, Robert Kaus, Timothy Kercher, Weidong Liu, Michael Lyon, Paul Nichols, Bin Wang, Tarek Sammakia, April Kennedy, Yutong Jiang
-
Publication number: 20090170380Abstract: An improved electrical connector for use with a glazing is disclosed. The glazing preferably comprises a ply of glazing material having a first electrically conductive component mounted thereon, and a second electrically conductive component, joined to the first by a solder. The second component comprises first and second connector feet linked by a bridge portion, the bridge portion being at a height h above each of the connector feet, and each of the feet comprises at least one protrusion having a height d. At least one of h or d is chosen to maximise the adhesion between the second electrically conductive component and the first electrically conductive component. Preferably, the glazing is an automotive glazing.Type: ApplicationFiled: March 23, 2007Publication date: July 2, 2009Inventor: Michael Lyon
-
Publication number: 20090155209Abstract: The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.Type: ApplicationFiled: May 2, 2008Publication date: June 18, 2009Inventors: LAWRENCE M. BLATT, LIN PAN, SCOTT SEIWERT, PIERRE MARTIN, ANDREAS SCHUMACHER, LEONID BEIGELMAN, JYANWEI LIU, STEVEN W. ANDREWS, KEVIN R. CONDROSKI, YUTONG JIANG, ROBERT J. KAUS, APRIL L. KENNEDY, TIMOTHY S. KERCHER, MICHAEL A. LYON, BIN WANG
-
Publication number: 20090148407Abstract: The embodiments provide compounds of the general Formulae (I) through general Formula (VIII), as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.Type: ApplicationFiled: July 17, 2006Publication date: June 11, 2009Applicants: Intermune, Inc., Array Biopharma Inc.Inventors: Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher, Bradley Barnett, C. Todd Eary, Robert Kaus, Timothy Kercher, Weidong Liu, Michael Lyon, Paul Nichols, Bin Wang, Tarek Sammakia, April Kennedy, Yutong Jiang